<?xml version="1.0" encoding="UTF-8"?>
<urlset xmlns="http://www.sitemaps.org/schemas/sitemap/0.9"
        xmlns:news="http://www.google.com/schemas/sitemap-news/0.9">
  <url>
    <loc>https://www.theedgeresearch.com/news</loc>
    <news:news>
      <news:publication>
        <news:name>TheEdgeResearch</news:name>
        <news:language>en</news:language>
      </news:publication>
      <news:publication_date>2026-10-24</news:publication_date>
      <news:title>First Russian diesel tanker heads to New York after Trump&apos;s deal with Putin to lower fuel prices</news:title>
    </news:news>
    <lastmod>2026-10-24</lastmod>
  </url>
  <url>
    <loc>https://www.theedgeresearch.com/quote/PURR</loc>
    <news:news>
      <news:publication>
        <news:name>TheEdgeResearch</news:name>
        <news:language>en</news:language>
      </news:publication>
      <news:publication_date>2026-10-24</news:publication_date>
      <news:title>Can Hyperliquid (HYPE) Get Back to $90 by the End of 2026?</news:title>
    </news:news>
    <lastmod>2026-10-24</lastmod>
  </url>
  <url>
    <loc>https://www.theedgeresearch.com/quote/UPS</loc>
    <news:news>
      <news:publication>
        <news:name>TheEdgeResearch</news:name>
        <news:language>en</news:language>
      </news:publication>
      <news:publication_date>2026-10-24</news:publication_date>
      <news:title>UPS Stock Is Down 57% From Its Record. Is It a Buy Before Its Oct. 27 Report?</news:title>
    </news:news>
    <lastmod>2026-10-24</lastmod>
  </url>
  <url>
    <loc>https://www.theedgeresearch.com/quote/GIL</loc>
    <news:news>
      <news:publication>
        <news:name>TheEdgeResearch</news:name>
        <news:language>en</news:language>
      </news:publication>
      <news:publication_date>2026-10-24</news:publication_date>
      <news:title>GIL Class Action Reminder - Robbins LLP Reminds Investors of the Lead Plaintiff Deadline in the Gildan Activewear Inc. Class Action Lawsuit</news:title>
    </news:news>
    <lastmod>2026-10-24</lastmod>
  </url>
  <url>
    <loc>https://www.theedgeresearch.com/quote/AMGN</loc>
    <news:news>
      <news:publication>
        <news:name>TheEdgeResearch</news:name>
        <news:language>en</news:language>
      </news:publication>
      <news:publication_date>2026-10-24</news:publication_date>
      <news:title>Amgen Inc. (AMGN) Presents at 2026 European Society for Medical Oncology (ESMO) Annual Congress Transcript</news:title>
    </news:news>
    <lastmod>2026-10-24</lastmod>
  </url>
  <url>
    <loc>https://www.theedgeresearch.com/quote/HYLN</loc>
    <news:news>
      <news:publication>
        <news:name>TheEdgeResearch</news:name>
        <news:language>en</news:language>
      </news:publication>
      <news:publication_date>2026-10-24</news:publication_date>
      <news:title>HYLN DEADLINE NOTICE: ROSEN, A LEADING LAW FIRM, Encourages Hyliion Holdings Corp. Investors to Secure Counsel Before Important October 27 Deadline in Securities Class Action - HYLN</news:title>
    </news:news>
    <lastmod>2026-10-24</lastmod>
  </url>
  <url>
    <loc>https://www.theedgeresearch.com/quote/FCEL</loc>
    <news:news>
      <news:publication>
        <news:name>TheEdgeResearch</news:name>
        <news:language>en</news:language>
      </news:publication>
      <news:publication_date>2026-10-24</news:publication_date>
      <news:title>FuelCell Energy, Inc. Class Action Reminder – Robbins LLP Encourages FCEL Investors to Contact the Firm for Information About Their Rights</news:title>
    </news:news>
    <lastmod>2026-10-24</lastmod>
  </url>
  <url>
    <loc>https://www.theedgeresearch.com/quote/UNCY</loc>
    <news:news>
      <news:publication>
        <news:name>TheEdgeResearch</news:name>
        <news:language>en</news:language>
      </news:publication>
      <news:publication_date>2026-10-24</news:publication_date>
      <news:title>UNCY DEADLINE NOTICE: ROSEN, A HIGHLY RECOGNIZED LAW FIRM, Encourages Unicycive Therapeutics, Inc. Investors to Secure Counsel Before Important November 2 Deadline in Securities Class Action - UNCY</news:title>
    </news:news>
    <lastmod>2026-10-24</lastmod>
  </url>
  <url>
    <loc>https://www.theedgeresearch.com/quote/EXEL</loc>
    <news:news>
      <news:publication>
        <news:name>TheEdgeResearch</news:name>
        <news:language>en</news:language>
      </news:publication>
      <news:publication_date>2026-10-24</news:publication_date>
      <news:title>Forget the FDA Delay: 3 Reasons Exelixis Is Still a Buy</news:title>
    </news:news>
    <lastmod>2026-10-24</lastmod>
  </url>
  <url>
    <loc>https://www.theedgeresearch.com/quote/MRNA</loc>
    <news:news>
      <news:publication>
        <news:name>TheEdgeResearch</news:name>
        <news:language>en</news:language>
      </news:publication>
      <news:publication_date>2026-10-24</news:publication_date>
      <news:title>Moderna, Inc. (MRNA) Discusses Phase III Data for Intismeran and Advances in Cancer Immunotherapy Transcript</news:title>
    </news:news>
    <lastmod>2026-10-24</lastmod>
  </url>
</urlset>
